Siddhartha S. Mitra, MS PhD

Affiliations: 
Institute for Stem Cell Biology and Regenerative Medicine Stanford University School of Medicine, Palo Alto, CA, United States 
Area:
Neural Stem Cells, Glioma Stem Cells
Google:
"Siddhartha Mitra"
Mean distance: 106866
 

Parents

Sign in to add mentor
Bruce J Nicholson grad student 2005 SUNY Buffalo
 (Understanding the crosstalk between receptor and non-receptor tyrosine kinase signal transduction pathways and Cx43 gap junctional communication.)
Irving L. Weissman research scientist 2010-2018 Stanford University Medical School (FlyTree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cole AP, Hoffmeyer E, Chetty SL, et al. (2020) Microglia in the Brain Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1273: 197-208
Theruvath J, Sotillo E, Mount CW, et al. (2020) Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors. Nature Medicine
Gholamin S, Youssef OA, Rafat M, et al. (2019) Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma. Innate Immunity. 1753425919876690
Mohanty S, Yerneni K, Theruvath JL, et al. (2019) Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma. Cell Death & Disease. 10: 36
Majzner RG, Theruvath JL, Nellan A, et al. (2019) CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Hutter G, Theruvath J, Graef CM, et al. (2019) Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Proceedings of the National Academy of Sciences of the United States of America
Kahn SA, Wang X, Nitta RT, et al. (2018) Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4651
Bakhshinyan D, Venugopal C, Adile AA, et al. (2018) BMI1 is a therapeutic target in recurrent medulloblastoma. Oncogene
Kahn SA, Wang X, Nitta RT, et al. (2018) Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4121
Gholamin S, Mitra SS, Feroze AH, et al. (2017) Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science Translational Medicine. 9
See more...